
|Articles|February 1, 2007
Broad-spectrum agent may be option for resistant UTIs
San Francisco-Community-acquired urinary tract infections are becoming increasingly difficult to treat in several countries due to the widespread increase in drug resistance. In Spain, isolated strains of Escherichia coli have become resistant to nearly all oral antimicrobials, reported Genoveva Yague III, MD, professor of microbiology at the University of Murcia Medical School, Murcia, Spain.
Advertisement
Newsletter
Stay current with the latest urology news and practice-changing insights — sign up now for the essential updates every urologist needs.
Advertisement
Related Content
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
NDV-01 produces robust 9-month results in high-risk NMIBC
2
Gemcitabine intravesical system delivers high 12-month DFS in papillary-only NMIBC
3
SUO 2025 data confirm IsoPSA accuracy independent of mpMRI use
4
SYNC-T demonstrates high bone metastasis resolution in phase 1 cohort
5

















